These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 26418967)

  • 1. A Model to Estimate Frozen Tissue Collection Targets in Biobanks to Support Cancer Research.
    Meredith AJ; Slotty A; Matzke L; Babinszky S; Watson PH
    Biopreserv Biobank; 2015 Oct; 13(5):356-62. PubMed ID: 26418967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Future of Biobanking: A Conceptual Look at How Biobanks Can Respond to the Growing Human Biospecimen Needs of Researchers.
    Somiari SB; Somiari RI
    Adv Exp Med Biol; 2015; 864():11-27. PubMed ID: 26420610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biospecimen Complexity-the Next Challenge for Cancer Research Biobanks?
    Watson PH
    Clin Cancer Res; 2017 Feb; 23(4):894-898. PubMed ID: 27551001
    [No Abstract]   [Full Text] [Related]  

  • 4. Biospecimen Complexity and the Evolution of Biobanks.
    Hartman V; Matzke L; Watson PH
    Biopreserv Biobank; 2019 Jun; 17(3):264-270. PubMed ID: 31188632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individual investigator profiles of biospecimen use in cancer research.
    Braun L; Lesperance M; Mes-Massons AM; Tsao MS; Watson PH
    Biopreserv Biobank; 2014 Jun; 12(3):192-8. PubMed ID: 24918606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biospecimen use correlates with emerging techniques in cancer research: impact on planning future biobanks.
    Cole A; Cheah S; Dee S; Hughes S; Watson PH
    Biopreserv Biobank; 2012 Dec; 10(6):518-25. PubMed ID: 24845138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biobankonomics: developing a sustainable business model approach for the formation of a human tissue biobank.
    Vaught J; Rogers J; Carolin T; Compton C
    J Natl Cancer Inst Monogr; 2011; 2011(42):24-31. PubMed ID: 21672892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Trends in Biospecimen Complexity in Cancer Research Over Two Decades.
    Wotton L; Gali B; Carvalho K; Tarling T; Matzke L; Watson PH
    Biopreserv Biobank; 2022 Apr; 20(2):195-200. PubMed ID: 34515517
    [No Abstract]   [Full Text] [Related]  

  • 9. Certification for biobanks: the program developed by the Canadian Tumour Repository Network (CTRNet).
    Matzke EA; O'Donoghue S; Barnes RO; Daudt H; Cheah S; Suggitt A; Bartlett J; Damaraju S; Johnston R; Murphy L; Shepherd L; Mes-Masson AM; Schacter B; Watson PH
    Biopreserv Biobank; 2012 Oct; 10(5):426-32. PubMed ID: 24845043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolutionary concepts in biobanking - the BC BioLibrary.
    Watson PH; Wilson-McManus JE; Barnes RO; Giesz SC; Png A; Hegele RG; Brinkman JN; Mackenzie IR; Huntsman DG; Junker A; Gilks B; Skarsgard E; Burgess M; Aparicio S; McManus BM
    J Transl Med; 2009 Nov; 7():95. PubMed ID: 19909513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of evolution in tumor biobanking on the interpretation of translational research.
    Barnes RO; Parisien M; Murphy LC; Watson PH
    Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3344-50. PubMed ID: 19064549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustainability in Biobanking: Model of Biobank Graz.
    Sargsyan K; Macheiner T; Story P; Strahlhofer-Augsten M; Plattner K; Riegler S; Granitz G; Bayer M; Huppertz B
    Biopreserv Biobank; 2015 Dec; 13(6):410-20. PubMed ID: 26697910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer donor preferences for disposition of their biospecimens after biobank closure.
    Allen SC; Dixon MD; Switchenko JM; Pentz RD
    Cancer; 2017 Dec; 123(23):4648-4652. PubMed ID: 28746751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biobank bootstrapping: is biobank sustainability possible through cost recovery?
    Albert M; Bartlett J; Johnston RN; Schacter B; Watson P
    Biopreserv Biobank; 2014 Dec; 12(6):374-80. PubMed ID: 25496148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Securing the sustainability of biobanks].
    Kirsten R; Hummel M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Mar; 59(3):390-5. PubMed ID: 26769112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biobanking 3.0: evidence based and customer focused biobanking.
    Simeon-Dubach D; Watson P
    Clin Biochem; 2014 Mar; 47(4-5):300-8. PubMed ID: 24406300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical Financial Challenges for Biobanking: Report of a National Cancer Institute Study.
    Rao A; Vaught J; Tulskie B; Olson D; Odeh H; McLean J; Moore HM
    Biopreserv Biobank; 2019 Apr; 17(2):129-138. PubMed ID: 30638412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current modalities and concepts on access and use of biospecimen samples and associated data for research from human biobanks].
    Siddiqui R; Semler SC
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Mar; 59(3):317-24. PubMed ID: 26809822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the financial, operational, and social sustainability of a biobank: the Wales Cancer Bank case study.
    Parry-Jones A
    Biopreserv Biobank; 2014 Dec; 12(6):381-8. PubMed ID: 25496149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Finding the Value in Biobanks: Enhancing the CTRNet Locator.
    Matzke LA; Tarling TE; Gali B; Dee S; LeBlanc J; Vercauteren S; Watson PH
    Biopreserv Biobank; 2022 Apr; 20(2):132-137. PubMed ID: 34252293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.